ChromaDex Corp., an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that it has established a $5 million credit facility with Bridge Bank.

The credit facility will provide ChromaDex non-dilutive working capital needed for future growth as the company continues to expand its proprietary ingredient business.

“We are pleased to have a business-focused bank available to the Company as the next step in our evolution,” said Tom Varvaro, ChromaDex CFO. “We look forward to working with Bridge Bank, which has a strong record of corporate banking and credit facilities for companies our size.”

Bridge Bank is a division of Western Alliance Bank, the go-to bank for business in its growing markets. Bridge Bank was founded in 2001 in Silicon Valley to offer a better way to bank for small-market and middle-market businesses across many industries, as well as emerging technology companies and the private equity community.

ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets.